Stocks · News reference
The agreement brings together Lifeward’s advanced personal exoskeleton technology and Ottobock Care’s established clinical expertise and regional patient care infrastructure. Through the pilot, the companies intend to
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-20 AccNo: 0001178913-26-004213 Size: 190 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarLifeward (NASDAQ:LFWD) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.34) by 8.96 percent. This is a 61.07 percent increase over losses of $(3.75) per share from the
Read original at benzinga